1.A pilot trial on the treatment of gastroesophageal reflux-related cough in infants.
Darryl J ADAMKO ; Carina M MAJAESIC ; Christopher SKAPPAK ; Adrian B JONES
Chinese Journal of Contemporary Pediatrics 2012;14(5):321-327
OBJECTIVEDiagnosing asthma in infancy is largely made on the basis of the symptoms of cough and wheezing. A similar presentation can be seen in neurologically normal infants with excessive gastroesophageal reflux (GER). There are no randomized placebo controlled studies in infants using proton pump inhibitors (PPI) alone or in addition to prokinetic agents. The primary objective was to confirm the presence of excessive GER in a population of infants that also had respiratory symptoms suggestive of asthma. Second, in a randomized placebo-controlled fashion, we determined whether treatment of GER with bethanacol and omeprazole could improve these respiratory symptoms.
METHODSInfants (n=22) with a history of chronic cough and wheeze were enrolled, if they had evidence of GER by history and an abnormal pH probe or gastric emptying scan. Infants were randomly allocated to four treatment groups: placebo/placebo (PP), omeprazole plus bethanacol (OB), omeprazole/placebo (OP), bethanacol/placebo (BP). Evaluations by clinic questionnaire and exam, home diary, and pH probe data were done before, after study-medication and after open label of OB.
RESULTSNineteen children were studied. PP did not affect GER or respiratory symptoms, and did not decrease GER measured by pH probe. In contrast, OB decreased GER as measured by pH probe indices and parental assessment. In association, OB significantly decreased daytime coughing and improved respiratory scores. No adverse effects were reported.
CONCLUSIONSIn infants with a clinical presentation suggestive of chronic GER-related cough, the use of omeprazole and bethanacol appears to be viable therapeutic option.
Bethanechol ; therapeutic use ; Cough ; drug therapy ; Double-Blind Method ; Female ; Gastroesophageal Reflux ; complications ; Humans ; Hydrogen-Ion Concentration ; Infant ; Male ; Omeprazole ; therapeutic use ; Pilot Projects ; Respiratory Sounds ; etiology
2.Malakoplakia in a healthy young female patient.
Kyung Hee HYUN ; Hyun Deok SHIN ; Dong Hoon KIM
The Korean Journal of Internal Medicine 2013;28(4):475-480
Malakoplakia is a rare granulomatous disease that occurs commonly in the urinary tract and secondarily in the gastrointestinal tract. Most reported cases of malakoplakia are associated with immunosuppressive diseases or chronic prolonged illness. Here, we report a rare case of malakoplakia in a young healthy adolescent without any underlying disease. A 19-year-old female was referred to our hospital following the discovery of multiple rectal polyps with sigmoidoscopy. She had no specific past medical history but complained of recurrent abdominal pain and diarrhea for 3 months. A colonoscopy revealed diverse mucosal lesions including plaques, polyps, nodules, and mass-like lesions. Histological examination revealed a sheet of histiocytes with pathognomonic Michaelis-Gutmann bodies. We treated the patient with ciprofloxacin, the cholinergic agonist bethanechol, and a multivitamin for 6 months. A follow-up colonoscopy revealed that her condition was resolved with this course of treatment.
Anti-Bacterial Agents/therapeutic use
;
Bethanechol/therapeutic use
;
Biopsy
;
Ciprofloxacin/therapeutic use
;
*Colon/drug effects/pathology
;
*Colonic Diseases/diagnosis/therapy
;
Colonoscopy
;
Drug Therapy, Combination
;
Female
;
Humans
;
*Intestinal Mucosa/drug effects/pathology
;
*Malacoplakia/diagnosis/therapy
;
Muscarinic Agonists/therapeutic use
;
Treatment Outcome
;
Vitamins/therapeutic use
;
Young Adult